Cargando…

A New Survival Score for Patients ≥65 Years Assigned to Radiotherapy of Bone Metastases

SIMPLE SUMMARY: Many cancer patients with bone metastases receive palliative radiotherapy. The patients’ remaining lifespan should be considered to achieve optimal treatment personalization. Since elderly patients (≥65 years) are different from younger ones, a specific survival score was developed f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rades, Dirk, Delikanli, Cansu, Schild, Steven E., Kristiansen, Charlotte, Tvilsted, Søren, Janssen, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563043/ https://www.ncbi.nlm.nih.gov/pubmed/36230602 http://dx.doi.org/10.3390/cancers14194679

Ejemplares similares

The First Survival Score for Patients Aged ≥80 Years Irradiated for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2022)

Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases
por: Rades, Dirk, et al.
Publicado: (2019)

An easy-to-use scoring system to estimate the survival of patients irradiated for bone metastases from lung cancer
por: Rades, Dirk, et al.
Publicado: (2020)

An Easy-To-Use Survival Score Compared to Existing Tools for Older Patients with Cerebral Metastases from Colorectal Cancer
por: Rades, Dirk, et al.
Publicado: (2020)

Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2019)

Early Identification of Pneumonitis in Patients Irradiated for Lung Cancer—Final Results of the PARALUC Trial
por: Rades, Dirk, et al.
Publicado: (2023)

A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases
por: Rades, Dirk, et al.
Publicado: (2017)

Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer – results of a randomized phase III trial (RAREST-02)
por: Rades, Dirk, et al.
Publicado: (2022)

A prospective interventional study evaluating seizure activity during a radiotherapy course for high-grade gliomas (SURF-ROGG)
por: Rades, Dirk, et al.
Publicado: (2021)

A New Instrument for Predicting Survival of Patients with Cerebral Metastases from Breast Cancer Developed in a Homogeneously Treated Cohort
por: Janssen, Stefan, et al.
Publicado: (2019)

A prospective interventional study investigating sleep disorders prior to and during adjuvant radiotherapy for breast cancer
por: Rades, Dirk, et al.
Publicado: (2021)

A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases
por: Rades, Dirk, et al.
Publicado: (2017)

The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2023)

Development of a multivariable prediction model to estimate the remaining lifespan of elderly patients with cerebral metastases from small-cell lung cancer
por: Rades, Dirk, et al.
Publicado: (2020)

Pneumonitis after radiotherapy for lung cancer (PARALUC): an interventional study to create a symptom-based scoring system for identification of patients developing radiation pneumonitis
por: Rades, Dirk, et al.
Publicado: (2020)

Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?
por: Rades, Dirk, et al.
Publicado: (2014)

A new score predicting the survival of patients with spinal cord compression from myeloma
por: Douglas, Sarah, et al.
Publicado: (2012)

Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis
por: Rades, Dirk, et al.
Publicado: (2020)

Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck
por: Rades, Dirk, et al.
Publicado: (2015)

A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer
por: Rades, Dirk, et al.
Publicado: (2012)

A validated score estimating ambulatory status following radiotherapy of elderly patients for metastatic spinal cord compression
por: Rades, Dirk, et al.
Publicado: (2014)

Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases
por: Johannwerner, Leonie, et al.
Publicado: (2023)

Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer
por: Rades, Dirk, et al.
Publicado: (2014)

Prevalence of metastases within the hypothalamic-pituitary area in patients with brain metastases
por: Janssen, Stefan, et al.
Publicado: (2019)

A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone
por: Huttenlocher, Stefan, et al.
Publicado: (2014)

Quality of life improvement in patients with bone metastases undergoing palliative radiotherapy
por: Cañón, Verónica, et al.
Publicado: (2022)

Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2020)

A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression
por: Rades, Dirk, et al.
Publicado: (2018)

Effects of different CT value assignment methods on dose calculations in radiotherapy planning for brain metastases
por: Ren, Jianxin, et al.
Publicado: (2020)

Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myeloma
por: Rades, Dirk, et al.
Publicado: (2016)

Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy
por: Rades, Dirk, et al.
Publicado: (2022)

Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis
por: Meyners, Thekla, et al.
Publicado: (2010)

Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy
por: Makita, Kenji, et al.
Publicado: (2023)

Radiotherapy with or without Decompressive Surgery for Metastatic Spinal Cord Compression: A Retrospective Matched-Pair Study Including Data from Prospectively Evaluated Patients
por: Rades, Dirk, et al.
Publicado: (2022)

Simple immobilization for stereotactic radiotherapy aimed at pelvic metastases
por: Janssen, Jorinde, et al.
Publicado: (2023)

Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m(2) for definitive radiochemotherapy of locally advanced head-and-neck cancers
por: Rades, Dirk, et al.
Publicado: (2016)

A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses
por: Rades, Dirk, et al.
Publicado: (2015)

LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2020)

Radiotherapy cannot prolong overall survival of young prostate cancer patients with bone metastases
por: Peng, Bo, et al.
Publicado: (2016)

Survival and Stability of Patients with Urothelial Cancer and Spinal Bone Metastases after Palliative Radiotherapy
por: Foerster, Robert, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ja3delk3eahf7gkah3p6m8hc82